Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-22-000023 General Corporate
Debt relative to revenue 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
198.42% · OPTIONAL · VALID
Capex intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.41% · OPTIONAL · VALID
Operating cash generation 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
5.09% · OPTIONAL · VALID
Revenue growth 20th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-1.95% · CORE · VALID
Inventory pressure 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
79.23% · OPTIONAL · VALID
Gross margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
37.50% · CORE · VALID
Operating margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
16.10% · CORE · VALID
R&D intensity 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.92% · OPTIONAL · VALID
SBC intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.62% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 209.17%
Current 198.42%
Delta -10.76% Capex Intensity Decreased
Previous 1.95%
Current 1.41%
Delta -0.54% Cash Generation Increased
Previous -22.22%
Current 5.09%
Delta 27.32% Growth Increased
Previous -6.30%
Current -1.95%
Delta 4.34% Inventory Pressure Decreased
Previous 80.10%
Current 79.23%
Delta -0.87% Margin Increased
Previous 36.00%
Current 37.50%
Delta 1.50% Profitability Increased
Previous 10.82%
Current 16.10%
Delta 5.28% R And D Intensity Increased
Previous 3.67%
Current 3.92%
Delta 0.24% Sbc Intensity Decreased
Previous 0.68%
Current 0.62%
Delta -0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.